Supplemental Choline and Brain Development in Humans
Supplemental Choline and Neurodevelopment in Humans
1 other identifier
interventional
150
1 country
1
Brief Summary
Studies have shown that choline is a necessary part of the human diet. Choline is important in making membranes for all the cells in the body, and for making chemicals that are responsible for nerve function. Studies have also shown that choline improves memory of rats when they are given choline at early stages in their lives. The purpose of this study is to find out whether choline supplementation (provided as a choline dietary supplement) in pregnant women will improve memory function of their babies after they are born. In this study, we hypothesize that high dietary choline consumption during pregnancy and lactation will:
- 1.Increase maternal choline concentration in plasma
- 2.Increase breast milk choline concentration
- 3.Enhance memory performance in the children born of supplemented mothers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Dec 2004
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 14, 2008
CompletedFirst Posted
Study publicly available on registry
May 16, 2008
CompletedJune 22, 2010
June 1, 2010
3 years
May 14, 2008
June 16, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Infant working memory
10 months & 12 months of age
Secondary Outcomes (2)
Breast milk choline concentration
45 & 90 days postpartum
Plasma choline concentrations
20 & 30 wks pregnancy, 45 & 90 days postpartum
Study Arms (2)
1
ACTIVE COMPARATORCholine supplement given from 18-weeks pregnancy through 90 days postpartum
2
PLACEBO COMPARATORPlacebo capsules given from 18 weeks pregnancy through 90 days postpartum
Interventions
850 mg per day from 18 weeks pregnancy through 90 days postpartum
Placebo capsules containing corn oil given from 18 weeks pregnancy through 90 days postpartum
Eligibility Criteria
You may qualify if:
- Less than 18 weeks pregnant
- Intends to breastfeed
- Receives regular prenatal care
- Takes a prenatal vitamin
You may not qualify if:
- Uses tobacco or illicit drugs
- Consumes alcohol
- History of chronic illness
- History of allergy to soy or corn
- Difficulty swallowing large capsules
- BMI \<18 or \>35
- Pregnant with more than 1 fetus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Gerber Foundationlead
- Egg Nutrition Centercollaborator
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
Related Publications (2)
Cheatham CL, Goldman BD, Fischer LM, da Costa KA, Reznick JS, Zeisel SH. Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012 Dec;96(6):1465-72. doi: 10.3945/ajcn.112.037184. Epub 2012 Nov 7.
PMID: 23134891DERIVEDFischer LM, da Costa KA, Galanko J, Sha W, Stephenson B, Vick J, Zeisel SH. Choline intake and genetic polymorphisms influence choline metabolite concentrations in human breast milk and plasma. Am J Clin Nutr. 2010 Aug;92(2):336-46. doi: 10.3945/ajcn.2010.29459. Epub 2010 Jun 9.
PMID: 20534746DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 14, 2008
First Posted
May 16, 2008
Study Start
December 1, 2004
Primary Completion
December 1, 2007
Study Completion
May 1, 2008
Last Updated
June 22, 2010
Record last verified: 2010-06